R&D of mRNA vaccine production technology against COVID-19 and further new coronavirus

(Innovation Center of NanoMedicine) The Innovation Center of NanoMedicine (iCONM) and the Tokyo Metropolitan Institute of Medical Science (TMIMS) started joint research with the aim of establishing a rapid vaccine development technology in preparation for the re-epidemic of covid-19 and the next coming pandemic of further new coronaviruses. An efficient procedure for the production of mRNA vaccine incorporated with immunostimulatory adjuvant functionality will be optimized using iCONM's smart na...